EAPCI Column

DOI:

EAPCI at EuroPCR 2025

With May comes EuroPCR, the annual official congress of the EAPCI, and this month the interventional cardiology community gathers, in Paris and online, for EuroPCR 2025. Once again, the EuroPCR Course Directors have developed an exciting programme combining the latest scientific advances with EuroPCR’s renowned educational content.  EAPCI members will play an active role throughout the congress, presenting hotline clinical trials, clinical cases and abstracts, as well as participating in the sessions. The programme is packed, and, irrespective of your focus – be it late-breaking clinical trials or hotline sessions, live cases, learning sessions or hands-on simulation − you will enjoy a packed programme with many opportunities to learn and interact with friends and colleagues, new and old. 

The action will begin on 19 May with many young interventional cardiologists joining the EAPCI-PCR Fellows Course. This course is dedicated to fellows and early career interventional cardiologists, with a full-day programme specifically developed to meet their needs. Case-based learning and relating the content to daily clinical practice are fundamental to the Course, with participants focusing on one unique topic in each of the five sessions. A specific session dedicated to presentation and communication skills equips young interventional cardiologists with key techniques to develop these skills early in their career and understand what makes the difference between average and exceptional presentations. In addition to the EAPCI-PCR Fellows Course, many young colleagues will be participating in PCR’s Got Talent, an innovative scientific abstract competition. Attend all three rounds of PCR’s Got Talent to learn from the high-quality research being carried out by young cardiologists worldwide.

In this year’s Hotline and Late-Breaking Trials sessions, there are numerous trials of interest to the community. In particular, Margaret McEntegart will present the outcomes of the EMPOWER CAD study, assessing the outcomes of intravascular lithotripsy in women with calcified coronary arteries. The topic of percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve intervention (TAVI) is of significant interest to the community, and Flavio Ribichini will present the outcomes of the FAITAVI trial, comparing angiography- versus physiology-guided PCI in patients undergoing TAVI. The results will no doubt provide a topic of discussion for the remainder of the congress. Finally, the results of “One-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in Acute Coronary Syndrome” will be presented by Woong Chol Kang. Maximising ischaemic benefits whilst reducing bleeding complications is always of interest to the community, and the results of this trial will add to the current evidence base.

This year’s winners of the EAPCI Fellowship Grants will have their awards presented in the Main Arena on 21 May at 14:45. EAPCI Fellowship Grants support interventional cardiology fellows to undergo a year-long period of training outside of their own country. The EAPCI is committed to equitable access to training for all and has allocated 50% of Fellowship Grants to men and 50% to women since 2018.

A key benefit of attending the congress each year for many participants is the live educational cases. This year’s live cases are an exciting combination of structural and coronary cases from Europe, North America and Saudi Arabia. EuroPCR 2025 opens with a live educational case focusing on PCI in a TAVI patient from the Clinique Pasteur in France. 

All EAPCI members are encouraged to attend the General Assembly on 20 May at 10:00 in Room 241. There will be two specific EAPCI case-based sessions in Room 252A: the first, on 21 May at 11:15, is presented by EAPCI President Alaide Chieffo and colleagues who will discuss antithrombotic drugs for acute coronary syndromes in women. The second focuses on identifying, preventing and managing complications of TAVI, and will be discussed on 22 May at 09:45.

The simulation learning room and hands-on lab provide opportunities for practical learning using simulation models – an ideal opportunity to enhance your knowledge of intravascular imaging or practise complication management in a controlled environment. Room 342A hosts the dedicated Nurses and Allied Professionals (NAPs) sessions, with abstracts and clinical cases submitted by NAPs as well as sessions built around the needs of the NAP community. New and updated content from the PCR-EAPCI Textbook will be released to complement the congress. As always, if you have any doubts, questions or simply wish to discuss EAPCI membership, please come to the EAPCI stand and meet with the team members. 

The 2025 edition of EuroPCR is sure to be a highly educational event and will provide our community with an opportunity to come together to meet, share opinions, and learn from each other. 

Volume 21 Number 10
May 16, 2025
Volume 21 Number 10
View full issue


Key metrics

Suggested by Cory

EAPCI Column

May 10, 2024
EAPCI focus on EuroPCR 2024
free

10.4244/EIJV10I1A6 May 20, 2014
May 2014, a very special month
Fajadet J
free

10.4244/EIJV11I3A50 Jul 20, 2015
Notes from the EAPCI general assembly
Windecker S
free

10.4244/EIJV10I3A52 Jul 21, 2014
Sustained progress through continuity: a new presidential criss-cross
Windecker S
free

10.4244/EIJV9I1A6 May 21, 2013
Sharing and growing together: EuroPCR 2013
Fajadet J
free

10.4244/EIJV13I17A326 Apr 20, 2018
May in Paris! Join us! EuroPCR 2018
Haude M
free

10.4244/EIJV8I5A83 Sep 28, 2012
The “Valve” Season is upon us
Fajadet J
free

10.4244/EIJV15I1A7 May 20, 2019
The year ahead: EAPCI milestones
Baumbach A
free
Trending articles
73.55

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
69.996

10.4244/EIJV13I12A217 Dec 8, 2017
Swimming against the tide: insights from the ORBITA trial
Al-Lamee R and Francis D
free
60.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
38.75

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
25.5

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved